HF Advisory Group, LLC

Position in PFE — Pfizer Inc

CIK 1963169 Annapolis, MD

Position in PFE

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$2,465,262

-$174,651 QoQ

Shares Held

102,378

+8.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.12%

of 13F equity value

Holder Rank

#869

of 2,821 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

HF Advisory Group, LLC holds $13,388,647 across 8 Drug Manufacturers - General names. PFE ranks #3 (18.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	23,463	$2,964,315
2	LLY	ELI LILLY & Co	2,246	$2,693,920
3	PFE	Pfizer Inc This page	102,378	$2,465,262
4	SNY	Sanofi	37,289	$1,590,748
5	NVS	Novartis AG	8,551	$1,340,112
6	JNJ	Johnson & Johnson	4,322	$1,097,658
7	AMGN	Amgen Inc	2,318	$839,394
8	GSK	GSK plc	7,578	$397,238

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,465,262	102,378	+8.9%	Shares	Sole	2026-07-09
2026-03-31	$2,639,913	94,014	+5.5%	Shares	Sole	2026-04-21
2025-12-31	$2,219,735	89,146	-40.3%	Shares	Sole	2026-01-23
2025-09-30	$3,805,463	149,351	+8.2%	Shares	Sole	2025-10-06
2025-06-30	$3,345,095	137,999	+25.6%	Shares	Sole	2025-07-10
2025-03-31	$2,784,055	109,868	+20.2%	Shares	Sole	2025-04-10
2024-12-31	$2,424,895	91,402	+3.3%	Shares	Sole	2025-01-15
2024-09-30	$2,560,784	88,486	-1.6%	Shares	Sole	2024-10-30
2024-06-30	$2,515,513	89,904	+9.0%	Shares	Sole	2024-07-18
2024-03-31	$2,288,681	82,475	+22.0%	Shares	Sole	2024-04-22
2023-12-31	$1,946,520	67,611	+20.5%	Shares	Sole	2024-01-31
2023-09-30	$1,861,898	56,132	+16.6%	Shares	Sole	2023-10-31
2023-06-30	$1,766,105	48,149	+15.2%	Shares	Sole	2023-07-20
2023-03-31	$1,704,868	41,786	+14.0%	Shares	Sole	2023-04-19
2022-12-31	$1,877,587	36,643	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.